In vitro and in vivo drug interactions involving human CYP3A
- PMID: 9597161
- DOI: 10.1146/annurev.pharmtox.38.1.389
In vitro and in vivo drug interactions involving human CYP3A
Abstract
Cytochrome P4503A (CYP3A) is importantly involved in the metabolism of many chemically diverse drugs administered to humans. Moreover, its localization in high amounts both in the small intestinal epithelium and liver makes it a major contributor to presystemic elimination following oral drug administration. Drug interactions involving enzyme inhibition or induction are common following the coadministration of two or more CYP3A substrates. Studies using in vitro preparations are useful in identifying such potential interactions and possibly permitting extrapolation of in vitro findings to the likely in vivo situation. Even if accurate quantitative predictions cannot be made, several classes of drugs can be expected to result in a drug interaction based on clinical experience. In many instances, the extent of such drug interactions is sufficiently pronounced to contraindicate the therapeutic use of the involved drugs.
Similar articles
-
Cytochrome P4503A (CYP3A) metabolism: prediction of in vivo activity in humans.J Pharmacokinet Biopharm. 1996 Oct;24(5):475-90. doi: 10.1007/BF02353475. J Pharmacokinet Biopharm. 1996. PMID: 9131486 Review.
-
P-glycoprotein and cytochrome P-450 3A inhibition: dissociation of inhibitory potencies.Cancer Res. 1999 Aug 15;59(16):3944-8. Cancer Res. 1999. PMID: 10463589
-
Interaction of cytochrome P450 3A inhibitors with P-glycoprotein.J Pharmacol Exp Ther. 2002 Oct;303(1):323-32. doi: 10.1124/jpet.102.037549. J Pharmacol Exp Ther. 2002. PMID: 12235267
-
Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: effect of ketoconazole.Clin Pharmacol Ther. 1999 Nov;66(5):461-71. doi: 10.1016/S0009-9236(99)70009-3. Clin Pharmacol Ther. 1999. PMID: 10579473
-
Factors confounding the successful extrapolation of in vitro CYP3A inhibition information to the in vivo condition.Eur J Pharm Sci. 2002 Apr;15(3):239-42. doi: 10.1016/s0928-0987(02)00002-7. Eur J Pharm Sci. 2002. PMID: 11923055 Review.
Cited by
-
Effect of CYP3A5 expression on the inhibition of CYP3A-catalyzed drug metabolism: impact on modeling CYP3A-mediated drug-drug interactions.Drug Metab Dispos. 2013 Aug;41(8):1566-74. doi: 10.1124/dmd.112.049940. Epub 2013 May 30. Drug Metab Dispos. 2013. PMID: 23723360 Free PMC article.
-
Single nucleotide polymorphism of CYP3A4 intron 2 and its influence on CYP3A4 mRNA expression and liver enzymatic activity in human liver.J Huazhong Univ Sci Technolog Med Sci. 2015 Aug;35(4):502-507. doi: 10.1007/s11596-015-1460-z. Epub 2015 Jul 31. J Huazhong Univ Sci Technolog Med Sci. 2015. PMID: 26223917
-
Effects of Flavonoids in Lysimachia clethroides Duby on the Activities of Cytochrome P450 CYP2E1 and CYP3A4 in Rat Liver Microsomes.Molecules. 2016 Jun 14;21(6):738. doi: 10.3390/molecules21060738. Molecules. 2016. PMID: 27314315 Free PMC article.
-
Transdermal use of phosphorodiamidate morpholino oligomer AVI-4472 inhibits cytochrome P450 3A2 activity in male rats.Pharm Res. 2002 Oct;19(10):1465-70. doi: 10.1023/a:1020448430919. Pharm Res. 2002. PMID: 12425463
-
Midazolam metabolism in cytochrome P450 3A knockout mice can be attributed to up-regulated CYP2C enzymes.Mol Pharmacol. 2008 Mar;73(3):1029-36. doi: 10.1124/mol.107.043869. Epub 2007 Dec 21. Mol Pharmacol. 2008. PMID: 18156313 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
